tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Holding LYEL?
Track your performance easily

Lyell Immunopharma (LYEL) Financial Statements

92 Followers

Lyell Immunopharma Financial Overview

Lyell Immunopharma's market cap is currently ―. The company's EPS TTM is $-0.801; its P/E ratio is -1.14; Lyell Immunopharma is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 34.00K$ 13.00K$ 3.00K$ 13.00K$ 25.00K
Gross Profit$ 34.00K$ 13.00K$ 3.00K$ 13.00K$ 25.00K
EBIT$ -44.58M$ -45.81M$ -60.67M$ -52.93M$ -59.04M
EBITDA$ -39.90M$ -36.54M$ -60.01M$ -41.66M$ -53.94M
Net Income Common Stockholders$ -44.58M$ -45.81M$ -60.67M$ -52.93M$ -50.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 440.55M$ 491.12M$ 526.30M$ 546.22M$ 575.43M
Total Assets$ 619.22M$ 654.14M$ 694.22M$ 750.03M$ 794.99M
Total Debt$ 51.44M$ 53.32M$ 55.16M$ 56.89M$ 58.58M
Net Debt$ -389.11M$ -437.80M$ -471.14M$ -489.33M$ -516.86M
Total Liabilities$ 88.52M$ 87.64M$ 91.06M$ 95.08M$ 97.42M
Stockholders Equity$ 530.70M$ 566.50M$ 603.16M$ 654.95M$ 697.57M
Cash Flow-
Free Cash Flow$ -35.10M$ -38.42M$ -42.05M$ -40.66M$ -37.88M
Operating Cash Flow$ -35.04M$ -38.09M$ -42.02M$ -40.63M$ -37.69M
Investing Cash Flow$ 1.92M$ 45.01M$ 21.99M$ -100.69M$ 99.67M
Financing Cash Flow-$ 862.00K$ 27.00K$ 759.00K$ -143.00K
Currency in USD

Lyell Immunopharma Earnings and Revenue History

Lyell Immunopharma Debt to Assets

Lyell Immunopharma Cash Flow

Lyell Immunopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis